Quantum-Si incorporated (QSI)

Market Cap	195.32M -41.0%
Revenue (ttm)	3.18M +40.2%
Net Income	-116.85M
EPS	-0.65
Shares Out	215.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,913,424
Open	0.9620
Previous Close	0.9388
Day's Range	0.9000 - 0.9772
52-Week Range	0.9000 - 3.1000
Beta	2.99
Analysts	Buy
Price Target	1.50 (+65.49%)
Earnings Date	Mar 3, 2026

About QSI

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an ava...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 149
• Stock Exchange: NASDAQ
• Ticker Symbol: QSI
• Website: https://www.quantum-si.com

Financial Performance

In 2024, Quantum-Si incorporated's revenue was $3.06 million, an increase of 182.62% compared to the previous year's $1.08 million. Losses were -$101.01 million, 5.26% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price target is $1.5, which is an increase of 65.49% from the latest price.

Price Target

$1.5

(65.49% upside)

Analyst Consensus: Buy